Abbott India Ltd share price logo

Abbott India Share Price

NSE: ABBOTINDIA

BSE: 500488

Mid Cap

Healthcare Sector

₹26350.00

+435.00

(+1.68%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Abbott India Stock Performance

as on April 1, 2026 at 5:31 pm IST

  • Day's Low

    Day's High

    ₹25,990.00
    ₹26,500.00
    downward going graph

    1.37%

    Downside

    0.57%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹25,350.00
    ₹37,000.00
    downward going graph

    3.80%

    Downside

    40.42%

    Upside

    downward going graph

Abbott India share price movements today

Previous Close
₹25,915.00
Open
₹26,345.00
Volume
3,506.00
Upper Circuit
₹31,095.00
Lower Circuit
₹20,735.00
Day's Low - High
₹25,990.00 - ₹26,500.00
52 Week Low - High
₹25,350.00 - ₹37,000.00

Abbott India Historical Returns

1 Month Return
-3.32 %
3 Month Return
-9.02 %
1 Year Return
-14.52 %
3 Year Return
+ 16.44 %
5 Year Return
+ 73 %

Abbott India Fundamentals

as on April 1, 2026 at 12:01 pm IST

Market Cap

₹55,069.38 Cr

Return on Equity (ROE)

35.66

PE Ratio (TTM)

0

Return on capital employed (ROCE)

44.95

Beta (LTM)

0.34

P/B Ratio

15.43

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

4.21

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bearish

View Technical Analysis

Abbott India Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abbott India with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Abbott India Ltd image
Abbott India Ltd
BUY55,069.3814.6%0.001,4146,445
Sanofi India Ltd image
Sanofi India Ltd
BUY7,391.94-11.97%0.524132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY75,759.769.6%0.603,48331,723
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
HOLD87,663.1119.44%0.614,61423,241
Glaxosmithkline Pharmaceuticals Ltd image
Glaxosmithkline Pharmaceuticals Ltd
BUY38,675.4011.88%0.569273,749
See all

Market expectation of Abbott India Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Abbott India Stock’s Investor Sentiment and Interest

Search interest for Abbott India Ltd Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-18% versus previous 30 day period

Abbott India Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
1,479
1,494.14
1,437.14
1,438.63
1,557.61
1,632.67
1,614.28
1,604.59
1,738.35
1,757.15
1,724.04
Other Income
56
55.51
55.61
81.15
67.33
60.48
71.75
76.02
72.84
69.95
69.76
Total Income
1,535
1,549.65
1,492.75
1,519.78
1,624.94
1,693.15
1,686.03
1,680.61
1,811.19
1,827.1
1,793.8
Expenses
1,124
1,113.26
1,049.45
1,109.1
1,166.6
1,193.71
1,178.19
1,176.05
1,292.76
1,254.98
1,260.57
Operating Profit
355
380.88
387.69
329.53
391.01
438.96
436.09
428.54
445.59
502.17
463.47
Operating Profit Margin %
24%
25.49%
26.98%
22.91%
25.1%
26.89%
27.01%
26.71%
25.63%
28.58%
26.88%
Profit Before Interest, Tax and Depreciation
411
436.39
443.3
410.68
458.34
499.44
507.84
504.56
518.43
572.12
533.23
Interest
3.34
3.13
3.17
2.81
2.75
2.5
2.26
3.92
5.82
7.55
5.48
Depreciation
17.17
17.84
17.97
18.19
18.37
17.51
17.99
17.93
19.48
18.64
18.77
Profit Before Tax
390.49
415.42
422.16
389.68
437.22
479.43
487.59
482.71
493.13
545.93
508.98
Tax Paid
100.25
102.48
111.18
102.62
109.21
120.82
126.81
115.67
127.27
130.66
133.02
Profit After Tax
290.24
312.94
310.98
287.06
328.01
358.61
360.78
367.04
365.86
415.27
375.96
Total Net profit including share of profit / Loss from associate company
290.24
312.94
310.98
287.06
328.01
358.61
360.78
367.04
365.86
415.27
375.96
EPS
136.58
147.27
146.34
135.09
154.36
168.76
169.78
172.72
172.17
195.42
176.92
Actual EPS
136.58
147.27
146.34
135.09
154.36
168.76
169.78
172.72
172.17
195.42
176.92
Adjusted EPS
136.58
147.27
146.34
135.09
154.36
168.76
169.78
172.72
172.17
195.42
176.92
Diluted EPS
136.58
147.24
146.34
135.09
154.36
168.76
169.78
172.72
172.17
195.42
176.92

Abbott India Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
3,298.5
3,678.6
4,093.14
4,310.02
4,913.32
5,348.73
5,848.91
6,409.15
Other Income
116.99
113.29
114.39
80.9
83.16
154.15
248.27
275.58
Total Income
3,415.49
3,791.89
4,207.53
4,390.92
4,996.48
5,502.88
6,097.18
6,684.73
Expenses
2,774
3,073.87
3,336.69
3,388.56
3,831.55
4,143.1
4,395.81
4,714.55
Operating Profit
524.5
604.73
756.45
921.46
1,081.77
1,205.63
1,453.1
1,694.6
Operating Profit Margin %
15.9%
16.44%
18.48%
21.38%
22.02%
22.54%
24.84%
26.44%
Profit Before Interest, Tax and Depreciation
641.49
718.02
870.84
1,002.36
1,164.93
1,359.78
1,701.37
1,970.18
Interest
3.82
2.25
8.53
18.28
19.1
15.99
12.45
11.43
Depreciation
16.19
16.92
59.61
58.13
66.1
69.97
71.17
71.8
Profit Before Tax
621.48
698.85
802.7
925.95
1,079.73
1,273.82
1,617.75
1,886.95
Tax Paid
220.26
248.52
209.77
235.26
281.03
324.41
416.53
472.51
Profit After Tax
401.22
450.33
592.93
690.69
798.7
949.41
1,201.22
1,414.44
Total Net profit including share of profit / Loss from associate company
401.22
450.33
592.93
690.69
798.7
949.41
1,201.22
1,414.44
EPS
188.81
211.93
279.04
325.04
375.86
446.78
565.28
665.62
Actual EPS
188.81
211.93
279.04
325.04
375.86
446.78
565.28
665.62
Adjusted EPS
188.81
211.93
279.04
325.04
375.86
446.78
565.28
665.62
Diluted EPS
188.81
211.93
279.04
325.04
375.86
446.78
565.28
665.62

Abbott India Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
248.68
307.22
152.7
499.13
626.11
726.74
947.66
893.39
1,212.81
1,011.84
Cash Flow from Investing Activities
-77.19
-155.42
-214.84
-257
-401.2
-71.82
-395.84
-147.71
-416.03
182.18
Cash Flow from Financing Activities
-80.29
-89.76
-102.43
-142.79
-216.79
-581.79
-637.38
-638.72
-744.71
-925.17
Net Cash Flow
91.19
62.05
-164.56
99.33
8.13
73.13
-85.56
106.96
52.07
268.85

Abbott India Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
74.99%
74.99%
74.99%
74.99%
74.99%
74.99%
74.99%
74.99%
74.99%
74.99%
74.99%
DII
8.67%
8.71%
8.74%
8.91%
8.81%
8.99%
9.01%
8.92%
9.19%
9.11%
9%
FII
0%
0%
0.18%
0.18%
0.18%
0.16%
0.16%
0.16%
0.16%
0.16%
0.18%
Public
16.04%
16%
16.1%
15.93%
16.02%
15.85%
15.84%
15.93%
15.66%
15.75%
15.83%
Total Outstanding Shares
2,12,49,302
2,12,49,302
2,12,49,302
2,12,49,302
2,12,49,302
2,12,49,302
2,12,49,302
2,12,49,302
2,12,49,302
2,12,49,302
2,12,49,302
Total Shareholders
69,582
68,885
72,252
69,382
71,588
69,449
67,892
69,934
67,584
71,199
75,801

Mutual Funds that own Abbott India Stock

Check out the Mutual Funds with significant holdings in Abbott India.

Abbott India Corporate Actions

View detailed summary of the earnings and dividend history of Abbott India.

  • Abbott India Ltd Earnings Results

    Abbott India Ltd’s net profit jumped 4.21% since last year same period to ₹375.96Cr in the Q3 2025-2026. On a quarterly growth basis, Abbott India Ltd has generated -9.47% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Abbott India Ltd Dividends May,2025

    In the quarter ending March 2025, Abbott India Ltd has declared dividend of ₹475.00 per share on 15 May 2025 - translating a dividend yield of 1.83%.

    Read More about Dividends

Indices Featuring Abbott India Stock

Check stock indices that include Abbott India.

BSE 200

₹10,382.75

2.23 (▲226.76%)

Nifty MNC

₹28,343.85

1.99 (▲552.60%)

Nifty 500

₹21,015.80

2.38 (▲487.75%)

S&P BSE 400 MidSmallCap

₹10,759.99

2.80 (▲293.54%)

BSE 500

₹32,944.16

2.37 (▲761.78%)

NIFTY PHARMA

₹22,287.75

0.25 (▲55.50%)

Nifty Midcap 150

₹19,936.55

2.60 (▲505.65%)

S&P BSE Quality

₹1,713.71

2.84 (▲47.36%)

Nifty Healthcare

₹14,207.00

0.04 (▲5.95%)

S&P BSE 150 MidCap

₹14,646.01

2.56 (▲365.05%)

BSE Healthcare

₹42,001.62

0.53 (▲223.24%)

Nifty MidSmallcap 400

₹18,012.30

2.78 (▲487.95%)

S&P BSE 250 LargeMidCap

₹9,851.05

2.27 (▲218.53%)

Nifty LargeMidcap 250

₹14,924.90

2.40 (▲350.40%)

Insights on Abbott India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 15.75% to 15.83% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.16% to 0.18% in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 32.6% return, outperforming this stock by 47.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 74.99% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Lupin Ltd has given 255.0% return, outperforming this stock by 238.6%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 7.78% to 7.65% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ABBOTINDIA stock has moved down by -1.9%

About Abbott India Ltd

Abbott India Ltd is a leading multinational pharmaceutical company in India, with its headquarters in Mumbai. It has manufacturing facilities in Goa and independent contract/third party manufacturers based across the country. The company provides products and solutions across therapeutic areas such as Womens Health, Gastroenterology, Central Nervous System, Metabolics, MultiSpecialty, Vaccines and Consumer Health. In 2002, they sold their Jejuri Undertakings with assets and liabilities as a going concern. In 2003, they amalgamated Knoll Pharmaceuticals Ltd with the company. In 2004, they started capsule production with a capacity of 27 million nos. and in 2005, they further increased the capacity to 56 million nos. and started a new project of producing nutritional products with installed capacity of 600 tonnes. In 2006, the production capacity of Tablets was also increased by 236 million nos to 686 million. In 2008, they launched Digene Total buffered pantoprazole tablet, Bruge, and Thyronorm 150 Digene along with Sugar Free Tablet and Gel. In 2018, Abbott India Ltd formed a new Business Unit GI Advance which followed a Build Operate Transfer model. During the year 2020-21, the company made an innovation in Brufen Coating formula leading to 50% increase in coating installed capacity. It further executed 8 new studies and published 8 articles in major indexed journals. Abbott India also launched 10 new products in various therapy segments leading to their recognition as The Most Innovative MNC of the Year 2019 at the 12th Pharma Leaders Award. The Drug Price Control Order 2013 brought several products of Abbott India under price control, leading to an adverse impact on sales and profits. They also received approvals to conduct phase 3 studies in adults/eldery and pediatric for their Influvac Quadrivalent Vaccine QIV Program. Abbott India has been making continuous efforts for portfolio expansion launching unique products and leveraging technology for better healthcare outcomes.

Revenue: ₹1,724.04Cr as on December 2025 (Q3 FY26)
Net Profit: ₹375.96Cr as on December 2025 (Q3 FY26)
Listing date: 03 Nov, 1994
Chairperson Name: Munir Shaikh
OrganisationAbbott India Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOMunir Shaikh
E-voting on sharesClick here to vote

FAQs

What is Abbott India share price today?

Abbott India share price today stands at ₹26350 as on . Abbott India share today touched a day high of ₹26500 and a low of ₹25990.

What is the 52 week high and 52 week low range for Abbott India share?

Abbott India touched a 52 week high of ₹37000 and a 52 week low of ₹25350. Abbott India share price today i.e. is trending at ₹26350, which is -28.78% down from its 52 week high and 3.94% up from its 52 week low.

What is Abbott India's market capitalisation today?

Abbott India market capitalisation is ₹55,069.38 Cr as on .

How to buy Abbott India shares?

To buy Abbott India shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ABBOTINDIA or Abbott India Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Abbott India shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Abbott India trading volume today?

Abbott India trading volume is 3,506.00 as on . This means that 3,506.00 shares of Abbott India were bought and sold on the stock market during today's trading session.